Robert W. Baird Forecasts Strong Price Appreciation for Healthpeak Properties (NYSE:DOC) Stock

Healthpeak Properties (NYSE:DOC) had its price target upped by analysts at Robert W. Baird from $19.00 to $21.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has an “outperform” rating on the real estate investment trust’s stock. Robert W. Baird’s price objective points to a potential upside of 6.21% from the stock’s previous close.

A number of other analysts also recently issued reports on DOC. Argus downgraded Healthpeak Properties from a “buy” rating to a “hold” rating in a research report on Thursday, February 5th. Evercore downgraded Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 price objective for the company. in a research report on Monday. Wall Street Zen raised Healthpeak Properties from a “sell” rating to a “hold” rating in a research report on Sunday. Wells Fargo & Company reissued a “positive” rating on shares of Healthpeak Properties in a research report on Tuesday, February 3rd. Finally, Scotiabank raised Healthpeak Properties to a “hold” rating in a research report on Thursday, April 23rd. Four analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $18.58.

Healthpeak Properties Stock Up 0.1%

Shares of NYSE:DOC opened at $19.77 on Wednesday. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15. The business has a fifty day moving average of $17.15 and a two-hundred day moving average of $17.18. The stock has a market cap of $13.63 billion, a P/E ratio of 61.79, a PEG ratio of 2.73 and a beta of 1.00. Healthpeak Properties has a 52-week low of $15.70 and a 52-week high of $19.87.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02. The firm had revenue of $752.95 million during the quarter, compared to the consensus estimate of $694.59 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The company’s quarterly revenue was up 7.1% on a year-over-year basis. During the same period last year, the company earned $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. On average, research analysts expect that Healthpeak Properties will post 1.74 earnings per share for the current year.

Hedge Funds Weigh In On Healthpeak Properties

Several hedge funds and other institutional investors have recently made changes to their positions in DOC. WPG Advisers LLC boosted its stake in shares of Healthpeak Properties by 270.2% in the 4th quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock valued at $26,000 after buying an additional 1,197 shares during the period. Advocate Investing Services LLC purchased a new position in shares of Healthpeak Properties in the 4th quarter valued at about $26,000. Elyxium Wealth LLC purchased a new position in shares of Healthpeak Properties in the 4th quarter valued at about $31,000. Clearstead Advisors LLC lifted its stake in Healthpeak Properties by 166.3% during the fourth quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock worth $31,000 after purchasing an additional 1,216 shares during the last quarter. Finally, CYBER HORNET ETFs LLC purchased a new stake in Healthpeak Properties during the second quarter worth approximately $33,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.